(CNN) — Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations ...

Weight loss drugs in next round of Medicare price negotiations Just days before leaving the office, President Biden expanded the list of medications to be negotiated by Medicare, including Ozempic and ...

CMS didn’t wait for Pres­i­dent-elect Don­ald Trump to take of­fice be­fore is­su­ing its sec­ond list of drugs to be ne­go­ti­at­ed un­der the In­fla­tion Re­duc­tion Act … ...

The buyouts are part of President Donald Trump's efforts to overhaul the government and reign in spending. Trump had called for “permanently” resettling Palestinians from war-torn Gaza and ...

The Centers for Medicare and Medicaid Services' (CMS) announcement of 15 new drugs to be subject to price controls under the Inflation Reduction Act (IRA) represents the continuation of a flawed ...

Medicare says that the drug added up to more than $14 billion covered by the program over the last year, the most of any medication in this round. The next costliest was GSK's asthma and chronic ...

(CNN) — Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the ...

No­vo Nordisk’s block­buster GLP-1 prod­ucts Ozem­pic and We­govy are among the next 15 drugs sub­ject to the gov­ern­ment’s Medicare ne­go­ti­a­tion pro­gram un­der the In­fla ...